|
|
 |
 |
|
|
|
|
|
Watson
Choices in Oral Contraceptives |
|
|
|
|
|
| | |  |  |
| |
| | | | | | |
| | |  | | Nordette®*
(levonorgestrel and ethinyl estradiol tablets, USP) | |
| | | | | | |
| | |  | | Lo-Ovral®*
(norgestrel and ethinyl estradiol tablets, USP) | |
| | | | | | |
| | |  | | Alesse®*
(levonorgestrel and ethinyl estradiol tablets, USP) | |
| | | | | | |
| | |  | | Loestrin®*
(norethindrone acetate and ethinyl estradiol tablets, USP) | |
| | | | | | |
| | |  | | Loestrin®*
(norethindrone acetate and ethinyl estradiol tablets, USP) | |
| | | | | | |
| | |  | | Loestrin®* Fe
(norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets*) | |
| | | | | | |
| | |  | | Loestrin®* Fe
(norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets*) | |
| | | | | | |
| | |  | | Ortho-Cyclen®*
(norgestimate and ethinyl estradiol tablets, USP) | |
| | | | | | |
| | |  | | Ortho Novum®* 1/35
(norethindrone and ethinyl estradiol tablets, USP) | |
| | | | | | |
| | |  | | Norinyl®* 1 + 50
(norethindrone and mestranol tablets, USP) | |
| | | | | | |
| | |  | | Ortho Novum®* 10/11
(Norethindrone and Ethinyl Estradiol Tablets) | |
| | | | | | |
| | |  | | Modicon®*
(norethindrone and ethinyl estradiol tablets, USP) | |
| | | | | | |
| | |  | |
| |
| | | | | | |
| | |  | |
| |
| | | | | | |
| | |  | | Ovral®*
(norgestrel and ethinyl estradiol tablets, USP) | |
| | | | | | |
| | |  | | Seasonale®*
(levonorgestrel and ethinyl estradiol tablets, USP) | |
| | | | | | |
| | |  | | Ortho-Cept®*
(desogestrel and ethinyl estradiol tablets, USP) | |
| | | | | | |
| | |  | | Levlite®*
(levonorgestrel and ethinyl estradiol tablets, USP) | |
| | | | | | |
| | |  | | Estrostep®* Fe
(norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets*) | |
| | | | | | |
| | |  | | Ovcon®* - 35
(norethindrone and ethinyl estradiol tablets, USP) | |
| | | | | | |
| | |  | | Demulen®*
(ethynodiol diacetate and ethinyl estradiol tablets, USP) | |
| | | | | | |
| | |  | | Demulen®*
(ethynodiol diacetate and ethinyl estradiol tablets, USP) | |
| | | | | | |
| | |  | | Tri-Norinyl®*
(norethindrone and ethinyl estradiol tablets, USP) | |
| | | | | | |
| | |  | | Ortho Novum®* 7/7/7
(norethindrone/ethinyl estradiol, USP) | |
| | | | | | |
| | |  | |
| |
| | | | | | |
| | |  | | Ortho Tri-Cyclen®*
(norgestimate and ethinyl estradiol tablets, USP) | |
| | | | | | |
| | |  | | Triphasil®*
(levonorgestrel and ethinyl estradiol tablets, USP - triphasic regimen) | |
| | | | | | |
| | |  | | Ortho Micronor®*
(norethindrone tablets) | |
| | | | | | |
| | |  | |
| |
| | | | | | |
| | |  | | Nor-QD®*
(norethindrone tablets, USP) | |
| | | | | | |
|
|
|
|
SAFETY
INFORMATION
Women who use oral contraceptives (OCs) should be strongly advised not to smoke
due to the increased risk of cardiovascular side effects. Serious risks reported
with the use of OCs include blood clots, stroke, and heart attacks. OCs are contraindicated
in women with thrombophlebitis, thromboembolic disorders, breast cancer, hepatic
or estrogen-dependent neoplasia, cerebrovascular or coronary artery disease, jaundice,
or undiagnosed genital bleeding. Risks associated with progestin-only OCs include
ectopic pregnancy and delayed follicular atresia. OCs do not protect against HIV
infection (AIDS) or other sexually transmitted diseases. |
|
|
|
|
|
*Brand names are the trademarks of the products' manufacturers and/or owners.
**Products illustrated may not appear at actual size and/or exact color.
|
|
